Orexin-A vs Davunetide

Head-to-head comparison of Orexin-A (Hypocretin-1 (Orexin-A)) and Davunetide (Activity-Dependent Neuroprotective Protein fragment NAP (NAPVSIPQ)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyOrexin-ADavunetide
CategoryCognitive EnhancementCognitive Enhancement
Full NameHypocretin-1 (Orexin-A)Activity-Dependent Neuroprotective Protein fragment NAP (NAPVSIPQ)
Molecular Weight3562 Da796.9 Da
Half-LifeMinutes to <1 hourshort; minutes to low hours
Amino Acids338
Typical DoseResearch-only; no validated human dose1-10 mg/day research range
RouteIntracerebroventricular/IntranasalIntranasal
Purity≥98%≥98%
Studies Count4240
Research StatusPre-clinicalClinical/Pre-clinical

Orexin-A Benefits

  • wakefulness
  • attention
  • memory consolidation
  • fatigue resistance

Davunetide Benefits

  • neuroprotection
  • microtubule support
  • attention support
  • memory preservation

Orexin-A Dosing

Research-only i.c.v. microgram/nanomolar studies|intranasal experimental use|no established human protocol

Davunetide Dosing

intranasal research dosing|1-10 mg per dose in trials/preclinical work|once or twice daily

Orexin-A Side Effects

  • insomnia
  • headache
  • blood pressure changes

Davunetide Side Effects

  • nasal irritation
  • headache
  • limited efficacy in late-stage trials

Research Overview

Orexin-A

Preclinical studies link orexin signaling to arousal, learning, and memory consolidation, making orexin-A a candidate for cognition-related research. It is not an approved cognitive enhancer and remains an experimental peptide.

Davunetide

Preclinical work showed davunetide can protect neurons, preserve synaptic structure, and improve performance in memory tasks. Human trials largely focused on neurodegenerative disease outcomes rather than stand-alone nootropic use, but the literature supports CNS activity.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Orexin-A stacks with:

PRL-8-53Bromantane

Davunetide stacks with:

gpenoopeptdesmopressin
peptidewakefulnessmemoryoctapeptideADNPneuroprotection